Outcome of cytoreductive surgery, treatment sequence and the differentiation status of T cells are key factors to take into account when studying the prognostic value of tumor-infiltrating lymphocytes (TIL) in high grade serous ovarian cancer.
CITATION STYLE
Wouters, M. C. A., Komdeur, F. L., de Bruyn, M., & Nijman, H. W. (2016). Size matters: Survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation. OncoImmunology, 5(5). https://doi.org/10.1080/2162402X.2015.1122863
Mendeley helps you to discover research relevant for your work.